Please use this identifier to cite or link to this item:
|Title:||Decreased expression of profilin 2 in oral squamous cell carcinoma and its clinicopathological implications|
Oral squamous cell carcinoma
|Citation:||Ma, C.Y., Zhang, C.P., Zhong, L.P., Pan, H.Y., Chen, W.T., Wang, L.Z., Andrew, O.W., Ji, T., Han, W. (2011). Decreased expression of profilin 2 in oral squamous cell carcinoma and its clinicopathological implications. Oncology Reports 26 (4) : 813-823. ScholarBank@NUS Repository. https://doi.org/10.3892/or.2011.1365|
|Abstract:||Profilins are small proteins essential for many normal cellular dynamics and constitute one of the crucial components of actin-based cellular motility. Several recent studies have implicated a role for the profilin (PFN) family in cancer pathogenesis and progression. However, their expression and promising functions are largely unknown in oral squamous cell carcinoma (OSCC). In this study, we analyzed the correlation between PFN1 and PFN2 expression in vitro and in vivo. The protein expression levels were roughly compared between cell lines (HIOEC, HB96) with the employment of mass spectrometry. PFN2 was singled out as one of the significantly down-regulated genes in the cancerous HB96 cells. The expression levels of PFN1 and PFN2 in vitro were validated by RT-PCR, real-time PCR and Western blotting. Laser scanning confocal microscopy was used for the first time to assess the localization of PFN2 expression. In subsequent experiments, we observed the relationship between PFN2 expression levels and the proliferation of transfected HB96 cancer cells. VASP, N-WASP and P27 expression was also examined in the PFN2-transfected or non-transfected HB96 cells. In vivo, antigen expression was determined by immunohistochemical analyses in 88 paired tissue specimens. Decreased protein expression was confirmed in cancerous tissues from 88 OSCC patients compared with paracancerous normal mucous epithelia. Tumors with weak PFN2 expression were associated with a significantly worse prognosis than strongly expressed tumours (P<0.001). Other statistical analyses were performed to assess the differences in expression and their clinical and pathological significance. In conclusion, PFN2 can be utilized as both a potential suppressor marker and a prognostic protein for OSCC. The function of PFN2 may be to regulate the N-WASP/Arp2/3 signaling pathway.|
|Source Title:||Oncology Reports|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jun 16, 2018
WEB OF SCIENCETM
checked on May 30, 2018
checked on Jun 2, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.